Document is current
Any future updates will be listed below
-
Authors
Walker, Brett S.
Sutton, Thomas L.
Zarour, Luai
Hunter, John G.
Wood, Stephanie G.
Tsikitis, V. Liana
Herzig, Daniel O.
Lopez, Charles D.
Chen, Emerson Y.
Mayo, Skye C.
Wong, Melissa H.
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-18-1-0621)
Oregon Health and Science University (Medical Research Foundation Early Clinical Investi)
National Cancer Institute (P30 CA069533)
Newton Esophageal Cancer Foundation (Esophageal Research Grant)
Collins Medical Trust (Research Grant)
- License Information
-
More Information
Article History
Received: 24 February 2021
Accepted: 17 June 2021
First Online: 7 August 2021
Disclosures
: EC: Investigator-initiated trial sponsored by Taiho Oncology, Inc. MW: Intellectual Property—Patents & Copyrights—circulating hybrid cell as a biomarker for disease status
